International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act

Author(s): Pore R David

Issue: Nov/Dec 2012 - Volume 16, Number 6
View All Articles in Issue

Page(s): 446-450

The Drug Enforcement Agency's Position on

Download in electronic PDF format for $75

Abstract: This article provides a summary of the Drug Enforcement Agency’s current interpretation of the Controlled Substances Act as it relates to the “constructive transfer” of certain controlled substances from pharmacist to physician for office administration. The article discusses compliance with the Controlled Substances Act in this context and related legislative and legal activities of individual pharmacists and of the International Academy of Compounding Pharmacists and other groups.

Related Keywords: R. David Pore, MA, JD, U.S. Drug Enforcement Agency, DEA, constructive transfer, Controlled Substances Act, DEA Form 222, compounded sterile preparations

Related Categories: LEGAL, PAIN MANAGEMENT, PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Pore R David	Nov/Dec 2012 Pg. 446-450
The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy Miller David G	Mar/Apr 2012 Pg. 94-96 View Sample
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
Standing Together Fixing the Drug Quality and Security Act Miller David G	Mar/Apr 2015 Pg. 104-106
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Gilbert John A	Sep/Oct 2009 Pg. 400-403
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Greeson Nicole MH, Mixon William, Allan W Chris	Sep/Oct 2020 Pg. 371-379
Compounding with Controlled Substances Whalen Mary Kate	Jan/Feb 2002 Pg. 8-10
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Miller David G	Jan/Feb 2014 Pg. 35-36
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Allen Loyd V Jr	Mar/Apr 2018 Pg. 92
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Miller David G	Sep/Oct 2012 Pg. 382-384
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R	Sep/Oct 2012 Pg. 431-433
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Miller David	Sep/Oct 2011 Pg. 382-384
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Martin Matt	Sep/Oct 2018 Pg. 401-404
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 1 Wagner James T	Mar/Apr 2006 Pg. 128-133
Return to Top